
Company
CEO message

CareMedi has developed an innovative proprietary electroosmotic pump technology capable of accurately and reliably controlling fluid delivery at the microliter (µL) level. Built upon this core technology, CareLevo®, our wearable insulin patch pump, is CareMedi’s first product designed to make a meaningful contribution to improving the quality of life for people living with diabetes. CareLevo features a 3 mL (300-unit) reservoir capacity—more than 1.5 times larger than many existing products—while enabling up to 7 days of use. At the same time, it achieves a slim and lightweight form factor, measuring only 11 mm in thickness and weighing just 17 g. In addition, we take pride in providing enhanced convenience through accurate and safe insulin delivery performance. True to the meaning behind the name “CareMedi,” we will continue developing medical devices that help more people enjoy healthier and happier lives, while delivering products our customers can trust.
Woonsup Shin,
CEO
